Seminar: Proteomic mapping reveals molecular determinants of FGF receptor signalling and trafficking

Dr. Jørgen Wesche, Group leader Molecular Biology of Sarcomas at Institute for Cancer Research, Oslo University Hospital

Published Sep. 22, 2017 11:37 AM - Last modified Sep. 25, 2017 3:20 PM